Stages and Symptoms of Colon Cancer

Colon cancer stages are graded from Stage 0 to Stage 4 according to the tumor’s progression through the intestinal wall, spread to the lymph nodes, and whether it has reached other organs; the most prominent symptoms of the disease are changes in bowel habits lasting longer than one week, narrowing of the stool, rectal bleeding, persistent abdominal pain, and weakness caused by iron deficiency. Staging, which is the most fundamental criterion in determining the treatment plan and survival rates, is performed using the TNM system and defines the limits of the surgical approach to be applied. The chance of early diagnosis and complete recovery depends on correctly interpreting these symptoms and performing the staging with precision.

What You Need to Know	Information
What is colon cancer?	It is a malignant tumor that begins on the inner surface of the large intestine and usually develops from precursor lesions called polyps. It may not cause symptoms in the early stage.
Stage 0	Cancer cells are found only on the inner surface of the intestine (mucosa). This stage is also called “carcinoma in situ.” The chance of complete recovery with treatment is high.
Stage I	The cancer has progressed into the deeper layers of the intestinal wall but has not spread to the lymph nodes or other organs. Treatment with surgery is possible.
Stage II	The tumor has grown beyond the intestinal wall. There is no spread to the lymph nodes. It is divided into substages (IIA, IIB, IIC). Additional treatment (chemotherapy) may be required.
Stage III	The cancer has spread to the regional lymph nodes. However, there is no spread to distant organs such as the liver or lungs. Chemotherapy is usually required after surgery.
Stage IV	The cancer has metastasized to distant organs. The aim of treatment generally focuses on prolonging survival and improving quality of life. Surgery, chemotherapy, and targeted treatments may be applied together.
Common symptoms	Changes in bowel habits (constipation, diarrhea), blood in the stool, rectal bleeding, abdominal pain, cramping, gas, bloating, weight loss, weakness, and iron deficiency anemia.
Possibility of having no symptoms	Early-stage colon cancers often do not cause symptoms. Therefore, screening tests, especially colonoscopy, are of great importance in early diagnosis.
Differences in symptoms according to the tumor	If the tumor is in the right colon, anemia and weakness are usually prominent; if it is in the left colon, narrowing of the stool, bleeding, and obstruction are more prominent.
Importance of early diagnosis	Colon cancer detected at an early stage can often be completely treated with surgery. If detected at the polyp stage, it can be removed before turning into cancer.

How Do Colon Cancer Symptoms Appear in the Body?

Unfortunately, colon cancer is a disease that progresses quite silently in its early stages. While the disease is still at the polyp stage or when the tumor is very small, a person may feel completely healthy. This silent period is one of the most dangerous aspects of the disease because when symptoms appear, the tumor has usually reached a certain size or has begun to affect intestinal functions. Our patients generally consult us after noticing certain changes in their bodies that do not seem normal. These symptoms may vary from person to person depending on the location of the tumor, its size, and the effects it creates.

The signals given by the body usually begin with irregularities in the digestive system. An unexplained change in bowel habits that have been regular for years is one of the most common complaints we encounter. Sometimes symptoms may also appear as general health problems that do not seem directly related to the digestive system.

The most common symptoms of the disease are:

• Persistent diarrhea
• Long-term constipation
• Narrowing of the stool diameter
• Fresh blood from the rectum
• Occult blood in the stool
• Abdominal pain
• Cramps
• Feeling of bloating
• Feeling that the bowels have not completely emptied
• Unexplained weight loss
• Severe weakness
• Getting tired easily
• Anemia

Why Do the Symptoms of Right- and Left-Sided Colon Cancer Differ?

The large intestine is anatomically a very long organ, and there are structural differences between its right and left sides. These differences directly change how the tumor develops and therefore the complaints experienced by the patient. Understanding this is very important for comprehending why symptoms vary from person to person.

The left side of the large intestine, which is the part closer to the rectum, has a narrower diameter. Tumors in this region usually grow by encircling the intestine like a ring. Since the intestinal lumen is already narrow, the passageway for stool becomes increasingly restricted as the tumor grows. Because of this physical obstruction, left-sided colon tumors reveal themselves with more obvious and noticeable symptoms. The patient has difficulty going to the toilet, experiences changes in bowel movements, and feels a sense of blockage. Since these disturbing symptoms compel the patient to see a doctor, left-sided tumors can generally be detected at an earlier stage. Colon cancer symptoms appear in different ways.

The main complaints caused by tumors on the left side are:

• Difficulty defecating
• Pencil-thin stools
• Abdominal cramps
• Feeling of obstruction
• Fresh red bleeding

On the other hand, the right side of the large intestine, which is the part where it joins the small intestine, has a much wider internal volume. Tumors developing here can reach very large sizes without causing intestinal obstruction. Because of the wide space, the passage of stool remains unaffected for a long time. However, due to their structure, these tumors tend to ulcerate and bleed insidiously. This bleeding is generally not visible to the naked eye; it mixes with the stool and goes unnoticed. The patient loses blood day by day, but because they do not realize it, they attribute their complaints to fatigue or old age.

The insidious symptoms seen in right-sided colon tumors are:

• Severe anemia
• Iron deficiency
• Weakness
• Palpitations
• Shortness of breath
• Occult blood in the stool

What Are the Risk Factors and Causes of Colon Cancer?

The development of colon cancer does not depend on a single cause; it emerges as a result of a complex interaction between our genetic inheritance and environmental factors. Some risk factors are based on causes beyond our control. Advancing age, a family history of cancer, or genetic predisposition are realities that we cannot change. However, modern lifestyle and dietary habits play a very significant role in the development of the disease.

The increase in colon cancer rates in developed countries and societies that adopt a Western-style lifestyle is not a coincidence. What we eat, what we drink, and how we live directly affect our intestinal health. There are many external factors that trigger inflammatory processes in our body and create a basis for cellular deterioration:

The main factors that increase the risk of the disease are:

• Advanced age
• Male sex
• Family history
• Inflammatory bowel diseases
• Polyps
• Red meat consumption
• Processed meat products
• Excessive alcohol use
• Smoking
• Obesity
• Sedentary lifestyle
• Low-fiber diet

How Are Colon Cancer Stages Determined and What Do They Mean?

After a cancer diagnosis is made, we need to determine the extent of the disease in the body, in other words its stage, in order to chart the course of treatment. As physicians, we use a classification system called TNM to establish a common language worldwide. This system allows us to create a picture of the disease and plan the most appropriate treatment for our patient.

The staging process is not merely a number; it is a vital assessment that affects every step, from the surgical decision to the need for chemotherapy. During this evaluation, the characteristics of the tumor itself, the condition of the lymph nodes, and the health of distant organs are closely examined.

The components of the TNM system are:

• Depth of the tumor
• Lymph node involvement
• Distant organ metastasis

Tumor depth (T) indicates how far the cancer has progressed through the layers of the intestinal wall. The intestinal wall consists of layers extending from the inside outward. Cancer begins in the innermost layer and gradually progresses outward, into the muscle layer, and then toward the surrounding tissues. Whether the tumor is only on the inner surface or has penetrated through the wall is one of the most important factors determining the surgical strategy.

Lymph node involvement (N) refers to whether cancer cells have broken away from the tumor and reached nearby lymph nodes through the lymphatic pathways. This is the first indicator of whether the disease has become systemic. If cancer cells are present in the lymph nodes, this generally indicates the need for additional treatments such as chemotherapy after surgery.

Distant organ metastasis (M) indicates whether the cancer has moved beyond the large intestine and settled in other organs such as the liver or lungs. With the combination of these three factors, the disease is graded from Stage 0 to Stage 4. In the early stages, Stage 1 and Stage 2, the disease is generally local, meaning it is confined to the intestine. In the advanced stages, Stage 3 and Stage 4, the disease has spread to the lymph nodes or other organs.

Why Are the CME Technique and Lymph Node Count Important in Surgical Treatment?

From the outside, colon cancer surgery may appear to involve only removing the diseased part of the intestine, but in oncological surgery, success lies in the details. The quality of the operation is one of the most important factors determining the patient’s future. The method we consider the gold standard in modern surgery is the “Complete Mesocolic Excision” (CME) technique.

Our intestines do not move freely within the abdominal cavity; they are suspended within a membrane structure called the mesocolon, which contains blood vessels and lymph nodes. When cancer cells begin to spread, they do not disperse randomly; they follow the lymphatic pathways inside this membrane. The CME technique aims to remove this envelope as a single package, together with all the lymph nodes and vascular structures inside it, without disrupting its integrity. This technique is a highly precise dissection procedure performed by the surgeon in accordance with embryological planes.

The most critical part of this technique is ligating the main vessels supplying the intestine at their roots and clearing the lymph nodes in that region through D3 lymphadenectomy. Especially in right-sided colon cancers, there is a possibility that tumor cells may spread to the lymph nodes at the root of the main vessels. If the surgeon removes only the intestine but leaves these deep lymph nodes behind, the risk of cancer recurrence increases.

The success of the operation is also reflected in the pathology report. The number of lymph nodes removed is an indicator of how comprehensively the surgery was performed. To perform accurate staging and determine whether the patient truly needs chemotherapy, at least 12 lymph nodes must be removed and examined. If this number is not reached, staging may remain incomplete, and the patient may be deprived of an additional treatment that could potentially save their life. Therefore, the technique and scope of surgery are at least as important as the stage of the disease.

The advantages provided by high-quality surgery are:

• More accurate staging
• Lower risk of recurrence
• Higher survival rate
• Reduced local recurrence
• Complete tumor clearance

What Advantages Does Robotic Surgery Offer in Colon Cancer Operations?

With technological advances, open operations in colon cancer surgery have largely been replaced by minimally invasive methods, namely laparoscopy and robotic surgery. Both methods fall under the umbrella of “Minimally Invasive Surgery” and offer patients a more comfortable recovery process compared with open surgery. However, robotic surgery stands out in some challenging cases due to the technical capabilities it provides to the surgeon.

Robotic systems allow the surgeon to view the surgical field in three dimensions, with high resolution and from a very close distance. However, the main difference lies in the mobility of the robotic arms. Thanks to instruments that imitate the movements of the human wrist and can even rotate more extensively, it becomes possible to work with millimetric precision in narrow and difficult-to-reach areas. Especially when applying the CME technique mentioned above, clearing the lymph nodes around the main vessels requires great attention and precision. Robotic surgery allows these delicate maneuvers to be performed more safely with its tremor-filtering technology and superior image quality.

Studies show that operations performed with robotic surgery involve less blood loss, allow patients to be discharged from the hospital sooner, and have a lower likelihood of conversion to open surgery during the operation. In addition, from an oncological perspective, it has been observed that the number of lymph nodes removed with robotic surgery is generally higher. This suggests that the technical superiority provided by the robot enables a more radical and cleaner surgical procedure. In terms of long-term outcomes, both laparoscopic and robotic surgery have similar success rates regarding cancer recovery and survival; however, the comfort during recovery and the technical ease during surgery make robotic surgery attractive.

The prominent technical benefits of robotic surgery are:

• High image quality
• Freedom of movement
• Low blood loss
• Rapid recovery
• Higher lymph node count
• Lower complication rate

How Is Early-Stage Colon Cancer Treatment Planned?

In the early stages of the disease, when the cancer has not yet spread to distant organs, the treatment approach is carefully determined according to the stage. In Stage 1, where the cancer remains confined to the intestinal wall and has not reached the lymph nodes, surgical intervention is generally sufficient on its own. Removing the tumor-containing segment and the associated lymph nodes through a successful operation allows the patient to regain complete health. These patients generally do not require additional chemotherapy, and the process is followed only through regular check-ups.

In Stage 2, the situation requires a somewhat more detailed evaluation. At this stage, the tumor may have passed through the intestinal wall and progressed toward the surrounding tissues, but there is still no lymph node involvement. A large proportion of Stage 2 patients recover with surgery alone. However, in some patients, the risk of the cancer returning is higher than in others. In this group, which we call “High-Risk Stage 2,” certain characteristics of the tumor lead us to be more cautious. For example, if the tumor has caused perforation of the intestine, invaded vascular structures, or if an adequate number of lymph nodes could not be removed during surgery, these patients are considered high risk.

At this point, innovations in the medical world come into play. The analysis of “Circulating Tumor DNA” (ctDNA), whose use has increased in recent years, is a very valuable technology that guides us. This sensitive test, performed on the patient’s blood after surgery, can detect whether microscopic cancer cell remnants remain in the body. If tumor DNA is detected in the blood, this indicates that the risk of disease recurrence is high. In this way, we can distinguish much more clearly which patient will benefit from chemotherapy and which patient can avoid receiving unnecessary chemotherapy.

The factors considered in high-risk situations are:

• Tumor perforation
• Intestinal obstruction
• Insufficient lymph node count
• Vascular invasion
• Nerve involvement
• Poor differentiation
• Positive ctDNA test

What Are the Treatment Options in Advanced-Stage and Metastatic Disease?

In the more advanced stages of the disease, namely Stage 3 and Stage 4, the treatment plan becomes a multidisciplinary approach requiring a joint decision from multiple specialties. Stage 3 refers to the condition in which cancer cells have spread to the lymph nodes around the tumor. For our patients at this stage, the standard treatment protocol is adjuvant chemotherapy administered after a successful surgical procedure. The main aim here is to destroy microscopic cells that may have spread throughout the body through the lymphatic system or bloodstream, even if the visible tumor has been removed through surgery. In this way, the risk of the disease recurring in the future is minimized.

In Stage 4, meaning metastatic disease, the situation changes completely. The cancer has now spread beyond the large intestine and settled in distant areas, most commonly the liver, but also the lungs or the peritoneum. In previous years, this stage was viewed as a period in which treatment options were very limited and hopelessness prevailed. However, thanks to advanced surgical techniques and powerful medications, Stage 4 has now become a manageable process and, in suitable patients, even a completely treatable one.

The most critical decision here is whether the metastases can be surgically removed. If the tumors in the liver or lungs are suitable for removal in terms of number and location, clearing these foci through operations called “Metastasectomy” significantly prolongs the patient’s life and may even provide complete recovery. Sometimes metastases may not initially be suitable for surgery. In this case, modern oncological medications and targeted molecules are used first to shrink the tumors, after which the possibility of surgery is reassessed. In short, even in metastatic disease, surgery has a very important place and significance; the aim is not only to remove the tumor but to perform a clearance that leaves no visible disease behind, known as an R0 resection.

The methods used in advanced-stage treatments are:

• Systemic chemotherapy
• Targeted drugs
• Immunotherapy
• Liver resection
• Lung resection
• Hyperthermic chemotherapy
• Palliative surgery
• Stent applications

How Should Life and Follow-Up Be Managed After Treatment?

Cancer treatment is not a process that ends with the last dose of chemotherapy or the healing of the surgical wound. We call this “tertiary prevention.” The period after treatment requires an active effort both to prevent recurrence of the disease and to improve the patient’s quality of life. Scientific data show us very clearly that unhealthy lifestyle habits that increase the risk of developing colon cancer also increase the risk of recurrence after treatment.

For this reason, the most important advice we give to patients who successfully complete their treatment is to thoroughly review their lifestyles. Healthy nutrition, regular physical activity, and avoiding harmful habits are as protective as medication treatments. In addition, depending on the genetic profile of our patients, it is known that even simple medications such as aspirin may be effective in preventing recurrence in some cases. Adhering to the follow-up schedule recommended by your doctor is vital for detecting a possible recurrence at the earliest stage.

The points to pay attention to after treatment are:

• Regular doctor check-ups
• Colonoscopy follow-up
• Blood tests
• CT scans
• Healthy nutrition
• Exercise
• Quitting smoking
• Weight control
• Aspirin use

Frequently Asked Questions

How Do Colon Cancer Stages Determine the Spread of the Disease?

Colon cancer stages are determined according to the depth of the tumor in the large intestine, spread to the lymph nodes, and metastasis to distant organs. While it is locally confined in the early stages, it may have spread throughout the body in advanced stages.

What Are the Symptoms of Colon Cancer Usually Like in the Early Stage?

Early-stage colon cancer generally does not cause symptoms. However, occult blood in the stool, unexplained fatigue, changes in bowel habits, and mild abdominal discomfort may be observed.

Which Symptoms Become More Prominent as Colon Cancer Progresses?

In advanced stages, symptoms such as blood in the stool, abdominal pain, weight loss, bloating, intestinal obstruction, and narrowing of the stool diameter are seen more frequently. These findings generally develop due to tumor growth.

Which Methods Stand Out in the Treatment of Stage 3 Colon Cancer?

In Stage 3 colon cancer, surgical removal of the tumor is essential. Chemotherapy is generally administered afterward. Due to lymph node involvement, systemic treatment becomes important.

What Factors Determine Survival in Stage 4 Colon Cancer?

In Stage 4, survival varies according to the organs to which the tumor has spread, the patient’s general health condition, response to treatment, and molecular characteristics. An individualized approach and targeted treatments affect the prognosis.

What Screening Tests Should Be Performed to Prevent Colon Cancer from Progressing to a Higher Stage?

Colonoscopy, fecal occult blood testing, and certain genetic tests are used for early diagnosis. Regular screening, especially for individuals over the age of 50, allows the disease to be detected before it progresses.

How Does Surgery Change Across Different Stages of Colon Cancer?

While laparoscopic tumor removal may be sufficient in the early stages, advanced stages may require more extensive bowel resection, lymph node dissection, and sometimes additional surgery for liver or lung metastases.

What Is the Role of Immunotherapy in Colon Cancer Treatment?

Immunotherapy may be effective in certain genetic subtypes, especially in patients who are MSI-H or dMMR positive. In advanced-stage patients, it may be used as an alternative to chemotherapy or in combination with it.

Who Has a Higher Risk of Developing Colon Cancer?

Family history, advanced age, inflammatory bowel diseases, a low-fiber diet, obesity, smoking, and physical inactivity are among the main factors that increase the risk of colon cancer.

What Should Be Considered During Follow-Up After Colon Cancer?

Regular colonoscopy, blood tests such as CEA, imaging methods, and lifestyle changes are important during post-treatment follow-up. The risk of recurrence is higher in the first 3-5 years, so close monitoring is required.